Rhythm Pharmaceuticals, Inc. financial data

Symbol
RYTM on Nasdaq
Industry
Pharmaceutical Preparations
Location
222 Berkeley Street, 12 Th Floor, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
RHYTHM METABOLIC, INC. (to 8/12/2015)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 406 % -35.3%
Quick Ratio 16.5 % +16.2%
Debt-to-equity 626 % +740%
Return On Equity -779 % -711%
Return On Assets -74.7 % -35.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.2M shares +3.69%
Common Stock, Shares, Outstanding 62.4M shares +4.99%
Entity Public Float 2.4B USD +171%
Common Stock, Value, Issued 61K USD +3.39%
Weighted Average Number of Shares Outstanding, Basic 61M shares +5.76%
Weighted Average Number of Shares Outstanding, Diluted 61.2M shares +5.78%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.3M USD +47.8%
Research and Development Expense 238M USD +76.3%
Costs and Expenses 396M USD +51.1%
Operating Income (Loss) -266M USD -44%
Nonoperating Income (Expense) 5.25M USD +2059%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -260M USD -41.4%
Income Tax Expense (Benefit) 346K USD
Net Income (Loss) Attributable to Parent -261M USD -41.1%
Earnings Per Share, Basic -4.34 USD/shares -35.6%
Earnings Per Share, Diluted -0.73 USD/shares +3.95%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 89.1M USD +48.4%
Cash, Cash Equivalents, and Short-term Investments 321M USD +16.2%
Accounts Receivable, after Allowance for Credit Loss, Current 18.5M USD +24.5%
Inventory, Net 18.7M USD +117%
Other Assets, Current 8.8M USD +31.9%
Assets, Current 374M USD +21.4%
Other Long-term Investments 7.33M USD -51.2%
Property, Plant and Equipment, Net 632K USD -52.9%
Operating Lease, Right-of-Use Asset 3.48M USD +345%
Other Assets, Noncurrent 7.33M USD -51.2%
Assets 392M USD +17.9%
Accounts Payable, Current 12.3M USD +152%
Accrued Liabilities, Current 62.7M USD +29.8%
Liabilities, Current 116M USD +109%
Operating Lease, Liability, Noncurrent 3.94M USD +704%
Other Liabilities, Noncurrent 35.6M USD
Liabilities 228M USD +39.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -39K USD -129%
Retained Earnings (Accumulated Deficit) -1.16B USD -29.1%
Stockholders' Equity Attributable to Parent 21.7M USD -87.2%
Liabilities and Equity 392M USD +17.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -40.7M USD -11.8%
Net Cash Provided by (Used in) Financing Activities 4.24M USD
Net Cash Provided by (Used in) Investing Activities 30.1M USD +62.7%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 62.4M shares +4.99%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.52M USD +63.8%
Deferred Tax Assets, Valuation Allowance 326M USD +21.8%
Deferred Tax Assets, Gross 327M USD +22.1%
Operating Lease, Liability 4.03M USD +180%
Payments to Acquire Property, Plant, and Equipment 47K USD -63%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -265M USD -43.5%
Lessee, Operating Lease, Liability, to be Paid 5.91M USD +278%
Property, Plant and Equipment, Gross 5.4M USD -0.02%
Operating Lease, Liability, Current 816K USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.1M USD +120%
Lessee, Operating Lease, Liability, to be Paid, Year One 456K USD -46.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD +1415%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.13M USD
Deferred Tax Assets, Operating Loss Carryforwards 167M USD +8.91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.15M USD
Additional Paid in Capital 1.18B USD +10.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 858K USD +64.6%
Deferred Tax Assets, Net of Valuation Allowance 1.2M USD +255%
Interest Expense 15.6M USD +55.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%